"Vaccines (Basel)"[Jour] - Search Results

Year	Number of Results
2012	2
2013	31
2014	39
2015	50
2016	48
2017	51
2018	84
2019	225
2020	787
2021	1559
2022	2215
2023	913

1

Vaccines against Tuberculosis: Where Are We Now?

Srivastava S, Dey S, Mukhopadhyay S. Srivastava S, et al. Vaccines (Basel). 2023 May 22;11(5):1013. doi: 10.3390/vaccines11051013. Vaccines (Basel). 2023. PMID: 37243117 Free PMC article. Review.

2

A Third Dose of SARS-CoV-2 mRNA Vaccine Improves Immune Response in Chronic Kidney Disease Patients.

Poli MC, Vial C, Rey-Jurado E, González N, Cortés LJ, Hormazabal J, Ramírez-Riffo C, de la Cruz J, Ulloa C. Poli MC, et al. Vaccines (Basel). 2023 May 22;11(5):1012. doi: 10.3390/vaccines11051012. Vaccines (Basel). 2023. PMID: 37243116 Free PMC article.

3

The Impact of Vaccination on COVID-19 Burden of Disease in the Adult and Elderly Population: A Systematic Review of Italian Evidence.

Calabrò GE, Pappalardo C, D'Ambrosio F, Vece M, Lupi C, Lontano A, Di Russo M, Ricciardi R, de Waure C. Calabrò GE, et al. Vaccines (Basel). 2023 May 22;11(5):1011. doi: 10.3390/vaccines11051011. Vaccines (Basel). 2023. PMID: 37243115 Free PMC article. Review.

4

COVID-19 Vaccination in the WHO African Region: Progress Made in 2022 and Factors Associated.

Mboussou F, Farham B, Nsasiirwe S, Atagbaza A, Oyaole D, Atuhebwe PL, Alegana V, Osei-Sarpong F, Bwaka A, Paluku G, Petu A, Efe-Aluta O, Kalu A, Bagayoko MM, Impouma B. Mboussou F, et al. Vaccines (Basel). 2023 May 22;11(5):1010. doi: 10.3390/vaccines11051010. Vaccines (Basel). 2023. PMID: 37243114 Free PMC article.

5

Flattening the Curve after the Initial Outbreak of Coronavirus Disease 2019: A Data-Driven Modeling Analysis for the Omicron Pandemic in China.

Sun J, Li Y, Xiao LF, Shao NY, Liu M. Sun J, et al. Vaccines (Basel). 2023 May 22;11(5):1009. doi: 10.3390/vaccines11051009. Vaccines (Basel). 2023. PMID: 37243113 Free PMC article.

6

Perceptions and Intention to Get Vaccinated against Mpox among the LGBTIQ+ Community during the 2022 Outbreak: A Cross-Sectional Study in Peru.

Araoz-Salinas JM, Ortiz-Saavedra B, Ponce-Rosas L, Soriano-Moreno DR, Soriano-Moreno AN, Alave J, Gonzales-Zamora JA. Araoz-Salinas JM, et al. Vaccines (Basel). 2023 May 21;11(5):1008. doi: 10.3390/vaccines11051008. Vaccines (Basel). 2023. PMID: 37243112 Free PMC article.

7

Subsequent Immunization of Pigs with African Swine Fever Virus (ASFV) Seroimmunotype IV Vaccine Strain FK-32/135 and by Recombinant Plasmid DNA Containing the CD2v Derived from MK-200 ASFV Seroimmunotype III Strain Does Not Protect from Challenge with ASFV Seroimmunotype III.

Sereda AD, Kazakova AS, Namsrayn SG, Vlasov ME, Sindryakova IP, Kolbasov DV. Sereda AD, et al. Vaccines (Basel). 2023 May 21;11(5):1007. doi: 10.3390/vaccines11051007. Vaccines (Basel). 2023. PMID: 37243111 Free PMC article.

8

Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models.

Lorenzo MM, Marín-López A, Chiem K, Jimenez-Cabello L, Ullah I, Utrilla-Trigo S, Calvo-Pinilla E, Lorenzo G, Moreno S, Ye C, Park JG, Matía A, Brun A, Sánchez-Puig JM, Nogales A, Mothes W, Uchil PD, Kumar P, Ortego J, Fikrig E, Martinez-Sobrido L, Blasco R. Lorenzo MM, et al. Vaccines (Basel). 2023 May 21;11(5):1006. doi: 10.3390/vaccines11051006. Vaccines (Basel). 2023. PMID: 37243110 Free PMC article.

9

Bovine Herpesvirus-4 Based Vaccine Provides Protective Immunity against Streptococcus suis Disease in a Rabbit Model.

Dong N, Nichols H, Sun Q, Chen X, Zheng J, Guan Z, Zhang H, Davison A, Wezel Y, Li Z, Li B, Liu K, Shao D, Qiu Y, Sun J, Li X, Upton M, Ma Z, Jarvis MA, Wei J. Dong N, et al. Vaccines (Basel). 2023 May 20;11(5):1004. doi: 10.3390/vaccines11051004. Vaccines (Basel). 2023. PMID: 37243109 Free PMC article.

10

A Booster with a Genotype-Matched Inactivated Newcastle Disease Virus (NDV) Vaccine Candidate Provides Better Protection against a Virulent Genotype XIII.2 Virus.

Hossain I, Subarna JF, Kabiraj CK, Begum JA, Parvin R, Martins M, Diel DG, Chowdhury EH, Islam MR, Nooruzzaman M. Hossain I, et al. Vaccines (Basel). 2023 May 20;11(5):1005. doi: 10.3390/vaccines11051005. Vaccines (Basel). 2023. PMID: 37243108 Free PMC article.

11

Comparison of the Immune Effects of an mRNA Vaccine and a Subunit Vaccine against Herpes Zoster Administered by Different Injection Methods.

Lin K, Cao H, Luan N, Wang Y, Hu J, Liu C. Lin K, et al. Vaccines (Basel). 2023 May 20;11(5):1003. doi: 10.3390/vaccines11051003. Vaccines (Basel). 2023. PMID: 37243107 Free PMC article.

12

The Quantification of Spike Proteins in the Inactivated SARS-CoV-2 Vaccines of the Prototype, Delta, and Omicron Variants by LC-MS.

Xu K, Sun H, Wang K, Quan Y, Qiao Z, Hu Y, Li C. Xu K, et al. Vaccines (Basel). 2023 May 20;11(5):1002. doi: 10.3390/vaccines11051002. Vaccines (Basel). 2023. PMID: 37243106 Free PMC article.

13

Adaptation and Validation of a French Version of the Vaccination Attitudes Examination (VAX) Scale.

Eisenblaetter M, Madiouni C, Laraki Y, Capdevielle D, Raffard S. Eisenblaetter M, et al. Vaccines (Basel). 2023 May 19;11(5):1001. doi: 10.3390/vaccines11051001. Vaccines (Basel). 2023. PMID: 37243105 Free PMC article.

14

No Difference in the Prevalence of HIV-1 gag Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana.

Mokaleng B, Choga WT, Bareng OT, Maruapula D, Ditshwanelo D, Kelentse N, Mokgethi P, Moraka NO, Motswaledi MS, Tawe L, Koofhethile CK, Moyo S, Zachariah M, Gaseitsiwe S. Mokaleng B, et al. Vaccines (Basel). 2023 May 19;11(5):1000. doi: 10.3390/vaccines11051000. Vaccines (Basel). 2023. PMID: 37243104 Free PMC article.

15

A First-in-Human Trial to Evaluate the Safety and Immunogenicity of a G Protein-Based Recombinant Respiratory Syncytial Virus Vaccine in Healthy Adults 18-45 Years of Age.

Cheng X, Zhao G, Dong A, He Z, Wang J, Jiang B, Wang B, Wang M, Huai X, Zhang S, Feng S, Qin H, Wang B. Cheng X, et al. Vaccines (Basel). 2023 May 18;11(5):999. doi: 10.3390/vaccines11050999. Vaccines (Basel). 2023. PMID: 37243103 Free PMC article.

16

Assessment of Safety and Prophylactic Efficacy of the EpiVacCorona Peptide Vaccine for COVID-19 Prevention (Phase III).

Ryzhikov AB, Ryzhikov EA, Bogryantseva MP, Usova SV, Nechaeva EA, Danilenko ED, Pyankov SA, Gudymo AS, Moiseeva AA, Onkhonova GS, Pyankov OV, Sleptsova ES, Lomakin NV, Vasilyeva VS, Tulikov MV, Gusarov VG, Pulin AA, Balalaeva MA, Erofeeva SB, Terpigorev SA, Rychkova OA, Petrov IM, Delian VY, Rafalskiy VV, Tyranovets SV, Gavrilova EV, Maksyutov RA. Ryzhikov AB, et al. Vaccines (Basel). 2023 May 18;11(5):998. doi: 10.3390/vaccines11050998. Vaccines (Basel). 2023. PMID: 37243102 Free PMC article.

17

Knowledge and Attitudes towards Human Papillomavirus Vaccination (HPV) among Healthcare Providers Involved in the Governmental Free HPV Vaccination Program in Shenzhen, Southern China.

Song D, Liu P, Wu D, Zhao F, Wang Y, Zhang Y. Song D, et al. Vaccines (Basel). 2023 May 18;11(5):997. doi: 10.3390/vaccines11050997. Vaccines (Basel). 2023. PMID: 37243101 Free PMC article.

18

Association between Overweight/Obesity and the Safety and Efficacy of COVID-19 Vaccination: A Systematic Review.

Fu C, Lin N, Zhu J, Ye Q. Fu C, et al. Vaccines (Basel). 2023 May 17;11(5):996. doi: 10.3390/vaccines11050996. Vaccines (Basel). 2023. PMID: 37243100 Free PMC article. Review.

19

Evaluation of IL-35, as a Possible Biomarker for Follow-Up after Therapy, in Chronic Human Schistosoma Infection.

Marascio N, Loria MT, Pavia G, Peronace C, Adams NJ, Campolo M, Divenuto F, Lamberti AG, Giancotti A, Barreca GS, Mazzitelli M, Trecarichi EM, Torti C, Perandin F, Bisoffi Z, Quirino A, Matera G. Marascio N, et al. Vaccines (Basel). 2023 May 17;11(5):995. doi: 10.3390/vaccines11050995. Vaccines (Basel). 2023. PMID: 37243099 Free PMC article.

20

The Influence of Recommendation of Medical and Non-Medical Authorities on the Decision to Vaccinate against Influenza from a Social Vaccinology Perspective: Cross-Sectional, Representative Study of Polish Society.

Sobierajski T, Rzymski P, Wanke-Rytt M. Sobierajski T, et al. Vaccines (Basel). 2023 May 17;11(5):994. doi: 10.3390/vaccines11050994. Vaccines (Basel). 2023. PMID: 37243098 Free PMC article.

21

HuNoV Non-Structural Protein P22 Induces Maturation of IL-1β and IL-18 and N-GSDMD-Dependent Pyroptosis through Activating NLRP3 Inflammasome.

Chen N, Chen P, Zhou Y, Chen S, Gong S, Fu M, Geng L. Chen N, et al. Vaccines (Basel). 2023 May 17;11(5):993. doi: 10.3390/vaccines11050993. Vaccines (Basel). 2023. PMID: 37243097 Free PMC article.

22

Bioprocessing and the Production of Antiviral Biologics in the Prevention and Treatment of Viral Infectious Disease.

Meade E, Rowan N, Garvey M. Meade E, et al. Vaccines (Basel). 2023 May 17;11(5):992. doi: 10.3390/vaccines11050992. Vaccines (Basel). 2023. PMID: 37243096 Free PMC article. Review.

23

IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein.

Uversky VN, Redwan EM, Makis W, Rubio-Casillas A. Uversky VN, et al. Vaccines (Basel). 2023 May 17;11(5):991. doi: 10.3390/vaccines11050991. Vaccines (Basel). 2023. PMID: 37243095 Free PMC article. Review.

24

Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium.

Postma MJ, Cheng CY, Buyukkaramikli NC, Hernandez Pastor L, Vandersmissen I, Van Effelterre T, Openshaw P, Simoens S. Postma MJ, et al. Vaccines (Basel). 2023 May 16;11(5):990. doi: 10.3390/vaccines11050990. Vaccines (Basel). 2023. PMID: 37243094 Free PMC article.

25

BNT162b2 COVID-19 Vaccines in Children, Adolescents and Young Adults with Cancer-A 1-Year Follow-Up.

Donze C, Min V, Ninove L, de Lamballerie X, Revon Rivière G, Verschuur A, Saultier P, André N. Donze C, et al. Vaccines (Basel). 2023 May 16;11(5):989. doi: 10.3390/vaccines11050989. Vaccines (Basel). 2023. PMID: 37243093 Free PMC article.

26

A Methodological Framework for Assessing the Benefit of SARS-CoV-2 Vaccination following Previous Infection: Case Study of Five- to Eleven-Year-Olds.

Pagel C, Wilde H, Tomlinson C, Mateen B, Brown K. Pagel C, et al. Vaccines (Basel). 2023 May 16;11(5):988. doi: 10.3390/vaccines11050988. Vaccines (Basel). 2023. PMID: 37243092 Free PMC article.

27

Future COVID-19 Booster Vaccine Refusal in Healthcare Workers after a Massive Breakthrough Infection Wave, a Nationwide Survey-Based Study.

Gu F, Lin H, Chen Z, Ambler G, Chen X, Chen X, Xia P, Liu N, Du H. Gu F, et al. Vaccines (Basel). 2023 May 16;11(5):987. doi: 10.3390/vaccines11050987. Vaccines (Basel). 2023. PMID: 37243091 Free PMC article.

28

Impact of COVID-19 Outbreak on Influenza and Pneumococcal Vaccination Uptake: A Multi-Center Retrospective Study.

Lan C, Chen YC, Chang YI, Chuang PC. Lan C, et al. Vaccines (Basel). 2023 May 15;11(5):986. doi: 10.3390/vaccines11050986. Vaccines (Basel). 2023. PMID: 37243090 Free PMC article.

29

Real-World Effectiveness of Four Types of COVID-19 Vaccines.

Abdel-Qader DH, Abdel-Qader H, Silverthorne J, Kongkaew C, Meslamani AZA, Hayajneh W, Alwahadneh AM, Hamadi S, Abu-Qatouseh L, Awad R, Al Nsour M, Alhariri A, Shnewer K, Da'ssan M, Obeidat NM, Nusair KE, Jalamdeh MS, Hawari F, Asad M, AbuRuz S. Abdel-Qader DH, et al. Vaccines (Basel). 2023 May 15;11(5):985. doi: 10.3390/vaccines11050985. Vaccines (Basel). 2023. PMID: 37243089 Free PMC article.

30

Estimating the Total Societal Cost of a Hexavalent Vaccine versus a Pentavalent Vaccine with Hepatitis B in South Korea.

Min S, Kwon SH, Lee YW, Lee JM, Bae EJ, Lee EK. Min S, et al. Vaccines (Basel). 2023 May 15;11(5):984. doi: 10.3390/vaccines11050984. Vaccines (Basel). 2023. PMID: 37243088 Free PMC article.

31

ANCA Associated Glomerulonephritis Following SARS-CoV-2 Vaccination: A Case Series and Systematic Review.

Thammathiwat T, Banjongjit A, Iampenkhae K, Townamchai N, Kanjanabuch T. Thammathiwat T, et al. Vaccines (Basel). 2023 May 15;11(5):983. doi: 10.3390/vaccines11050983. Vaccines (Basel). 2023. PMID: 37243087 Free PMC article. Review.

32

Mucosal Vaccination with Live Attenuated Bordetella bronchiseptica Protects against Challenge in Wistar Rats.

Chamorro BM, Luca K, Swaminathan G, Rochereau N, Majorel J, Poulet H, Chanut B, Piney L, Mundt E, Paul S. Chamorro BM, et al. Vaccines (Basel). 2023 May 15;11(5):982. doi: 10.3390/vaccines11050982. Vaccines (Basel). 2023. PMID: 37243086 Free PMC article.

33

Determinants of COVID Vaccination Willingness among Health and Non-Health Studies Students: A Cross-Sectional Study.

Marendić M, Aranza D, Aranza I, Vrdoljak D, Podrug M, Milić M. Marendić M, et al. Vaccines (Basel). 2023 May 15;11(5):981. doi: 10.3390/vaccines11050981. Vaccines (Basel). 2023. PMID: 37243085 Free PMC article.

34

Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV-Data from ECEE Network Group.

Aimla K, Kowalska JD, Matulionyte R, Mulabdic V, Vassilenko A, Bolokadze N, Jilich D, Antoniak S, Oprea C, Balayan T, Harxhi A, Papadopoulos A, Lakatos B, Vasylyev M, Begovac J, Yancheva N, Streinu-Cercel A, Verhaz A, Gokengin D, Dragovic G, Sojak L, Skrzat-Klapaczyńska A; Euroguidelines in Central and Eastern Europe Network Group. Aimla K, et al. Vaccines (Basel). 2023 May 14;11(5):980. doi: 10.3390/vaccines11050980. Vaccines (Basel). 2023. PMID: 37243084 Free PMC article.

35

Real-World Safety and Efficacy Clinical Data of an Improved Allergen-Specific Immunotherapy Product for the Treatment of Bee Venom Allergy.

Gonzalez Guzman LA, García Robaina JC, Barrios Recio J, Escudero Arias E, Liñares Mata T, Cervera Aznar R, De La Roca Pinzón F, Miguel Polo LDC, Arenas Villarroel L, López Couso VP, Alcover Diaz J, Rodriguez Gil D, Pelaez RP, Carballada Gonzalez FJ. Gonzalez Guzman LA, et al. Vaccines (Basel). 2023 May 13;11(5):979. doi: 10.3390/vaccines11050979. Vaccines (Basel). 2023. PMID: 37243083 Free PMC article.

36

Results on SARS-CoV-2 mRNA Vaccine Booster from an Open-Label Multicenter Study in Ofatumumab-Treated Participants with Relapsing Multiple Sclerosis.

Ziemssen T, Schlegel E, Groth M, Ettle B, Bopp T. Ziemssen T, et al. Vaccines (Basel). 2023 May 13;11(5):978. doi: 10.3390/vaccines11050978. Vaccines (Basel). 2023. PMID: 37243082 Free PMC article.

37

Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV.

Azizi H, Knapp JP, Li Y, Berger A, Lafrance MA, Pedersen J, de la Vega MA, Racine T, Kang CY, Mann JFS, Dikeakos JD, Kobinger G, Arts EJ. Azizi H, et al. Vaccines (Basel). 2023 May 12;11(5):977. doi: 10.3390/vaccines11050977. Vaccines (Basel). 2023. PMID: 37243081 Free PMC article.

38

A Case-Control Study on Factors of HPV Vaccination for Mother and Daughter in China.

Chen L, Sun X, Luo J, Zhang Y, Ha Y, Xu X, Tao L, Mu X, Gao S, Han Y, Wang C, Wang F, Wang J, Yang B, Guo X, Yu Y, Ma X, Liu L, Ma W, Xie P, Wang C, Li G, Lu Q, Cui F. Chen L, et al. Vaccines (Basel). 2023 May 12;11(5):976. doi: 10.3390/vaccines11050976. Vaccines (Basel). 2023. PMID: 37243080 Free PMC article.

39

Optimizing the Production of gp145, an HIV-1 Envelope Glycoprotein Vaccine Candidate and Its Encapsulation in Guanosine Microparticles.

Akamine P, González-Feliciano JA, Almodóvar R, Morell G, Rivera J, Capó-Vélez CM, Delgado-Vélez M, Prieto-Costas L, Madera B, Eichinger D, Pino I, Rivera JH, Ortiz-Ubarri J, Rivera JM, Baerga-Ortiz A, Lasalde-Dominicci JA. Akamine P, et al. Vaccines (Basel). 2023 May 12;11(5):975. doi: 10.3390/vaccines11050975. Vaccines (Basel). 2023. PMID: 37243079 Free PMC article.

40

Experiences, Enablers, and Challenges in Service Delivery and Integration of COVID-19 Vaccines: A Rapid Systematic Review.

Nabia S, Wonodi CB, Vilajeliu A, Sussman S, Olson K, Cooke R, Udayakumar K, Twose C, Ezeanya N, Adefarrell AA, Lindstrand A. Nabia S, et al. Vaccines (Basel). 2023 May 11;11(5):974. doi: 10.3390/vaccines11050974. Vaccines (Basel). 2023. PMID: 37243078 Free PMC article. Review.

41

COVID-19 Vaccine Perceptions among Ebola-Affected Communities in North Kivu, Democratic Republic of the Congo, 2021.

Garbern SC, Perera SM, Mbong EN, Kulkarni S, Fleming MK, Ombeni AB, Muhayangabo RF, Tchoualeu DD, Kallay R, Song E, Powell J, Gainey M, Glenn B, Gao H, Mutumwa RM, Mustafa SHB, Abad N, Soke GN, Prybylski D, Doshi RH, Fukunaga R, Levine AC. Garbern SC, et al. Vaccines (Basel). 2023 May 11;11(5):973. doi: 10.3390/vaccines11050973. Vaccines (Basel). 2023. PMID: 37243077 Free PMC article.

42

COVID-19 Prevention Behaviours and Vaccine Acceptability, and Their Association with a Behaviour Change Campaign in Somalia: Analysis of a Longitudinal Cohort.

Seal A, Jelle M, Hassan MY, Farah DA, Musili FM, Micheni J, Asol GS, Bhandari M, Nemeth B. Seal A, et al. Vaccines (Basel). 2023 May 11;11(5):972. doi: 10.3390/vaccines11050972. Vaccines (Basel). 2023. PMID: 37243076 Free PMC article.

43

Selection Effects and COVID-19 Mortality Risk after Pfizer vs. Moderna Vaccination: Evidence from Linked Mortality and Vaccination Records.

Atanasov V, Barreto N, Whittle J, Meurer J, Weston BW, Luo QE, Yuan AY, Franchi L, Zhang R, Black B. Atanasov V, et al. Vaccines (Basel). 2023 May 11;11(5):971. doi: 10.3390/vaccines11050971. Vaccines (Basel). 2023. PMID: 37243075 Free PMC article.

44

Experimental Medicine for HIV Vaccine Research and Development.

Prudden H, Tatoud R, Slack C, Shattock R, Anklesaria P, Bekker LG, Buchbinder S. Prudden H, et al. Vaccines (Basel). 2023 May 11;11(5):970. doi: 10.3390/vaccines11050970. Vaccines (Basel). 2023. PMID: 37243074 Free PMC article.

45

Serological Response to SARS-CoV-2 after COVID-19 Vaccination in Lung Cancer Patients: Short Review.

Rodilla AM, Tavolacci S, Cagan J, Shah T, Mittan S, Mack PC, Hirsch FR. Rodilla AM, et al. Vaccines (Basel). 2023 May 11;11(5):969. doi: 10.3390/vaccines11050969. Vaccines (Basel). 2023. PMID: 37243073 Free PMC article. Review.

46

Clinical Characteristics of Mild Patients with Breakthrough Infection of Omicron Variant in China after Relaxing the Dynamic Zero COVID-19 Policy.

He Y, Zhang F, Liu Y, Xiong Z, Zheng S, Liu W, Liu L. He Y, et al. Vaccines (Basel). 2023 May 10;11(5):968. doi: 10.3390/vaccines11050968. Vaccines (Basel). 2023. PMID: 37243072 Free PMC article.

47

Adolescents' Opinions on COVID-19 Vaccine Hesitancy: Hints toward Enhancing Pandemic Preparedness in the Future.

Muscillo A, Lombardi G, Sestini E, Garbin F, Tambone V, Campanozzi LL, Pin P. Muscillo A, et al. Vaccines (Basel). 2023 May 10;11(5):967. doi: 10.3390/vaccines11050967. Vaccines (Basel). 2023. PMID: 37243071 Free PMC article.

48

Potential of Nucleic Acid Receptor Ligands to Improve Vaccination Efficacy against the Filarial Nematode Litomosoides sigmodontis.

Scheunemann JF, Risch F, Reichwald JJ, Lenz B, Neumann AL, Garbe S, Frohberger SJ, Koschel M, Ajendra J, Rothe M, Latz E, Coch C, Hartmann G, Schumak B, Hoerauf A, Hübner MP. Scheunemann JF, et al. Vaccines (Basel). 2023 May 10;11(5):966. doi: 10.3390/vaccines11050966. Vaccines (Basel). 2023. PMID: 37243070 Free PMC article.

49

A Plant-Derived Maternal Vaccine against Porcine Epidemic Diarrhea Protects Piglets through Maternally Derived Immunity.

Sohn EJ, Kang H, Min K, Park M, Kim JH, Seo HW, Lee SJ, Kim H, Tark D, Cho HS, Choi BH, Oh Y. Sohn EJ, et al. Vaccines (Basel). 2023 May 9;11(5):965. doi: 10.3390/vaccines11050965. Vaccines (Basel). 2023. PMID: 37243069 Free PMC article.

50

Acceptance of COVID-19 Vaccines in India: A Systematic Review and Meta-Analysis.

Kumar G, Jena S, Snigdha NT, Basha S, Narayanan JK, Luke AM. Kumar G, et al. Vaccines (Basel). 2023 May 9;11(5):964. doi: 10.3390/vaccines11050964. Vaccines (Basel). 2023. PMID: 37243068 Free PMC article.

51

Long-Term Cross Immune Response in Mice following Heterologous Prime-Boost COVID-19 Vaccination with Full-Length Spike mRNA and Recombinant S1 Protein.

Li D, Zhao H, Liao Y, Jiang G, Cui P, Zhang Y, Yu L, Fan S, Li H, Li Q. Li D, et al. Vaccines (Basel). 2023 May 9;11(5):963. doi: 10.3390/vaccines11050963. Vaccines (Basel). 2023. PMID: 37243067 Free PMC article.

52

Antiviral Response across Genotypes after Treatment of Chronic Hepatitis B Patients with the Therapeutic Vaccine NASVAC or Pegylated Interferon.

Al-Mahtab M, Akbar SMF, Yoshida O, Aguilar JC, Guillen G, Hiasa Y. Al-Mahtab M, et al. Vaccines (Basel). 2023 May 9;11(5):962. doi: 10.3390/vaccines11050962. Vaccines (Basel). 2023. PMID: 37243066 Free PMC article. Review.

53

Potency of Veterinary Rabies Vaccines Marketed in Sri Lanka.

Rathnadiwakara H, Gunatilake M, Servat A, Wasniewski M, Thibault JC, Cliquet F. Rathnadiwakara H, et al. Vaccines (Basel). 2023 May 9;11(5):961. doi: 10.3390/vaccines11050961. Vaccines (Basel). 2023. PMID: 37243065 Free PMC article.

54

COVID-19 Vaccination Hesitancy among Youths in Soweto, South Africa.

Muthoni J, Otwombe K, Thaele D, Choge I, Steenberg B, Cutland C, Madhi SA, Sokani A, Myburgh N. Muthoni J, et al. Vaccines (Basel). 2023 May 9;11(5):960. doi: 10.3390/vaccines11050960. Vaccines (Basel). 2023. PMID: 37243064 Free PMC article.

55

NS1 Protein N-Linked Glycosylation Site Affects the Virulence and Pathogenesis of Dengue Virus.

Fang E, Li M, Liu X, Hu K, Liu L, Zhang Z, Li X, Peng Q, Li Y. Fang E, et al. Vaccines (Basel). 2023 May 8;11(5):959. doi: 10.3390/vaccines11050959. Vaccines (Basel). 2023. PMID: 37243063 Free PMC article.

56

SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers.

Regenhardt E, Kirsten H, Weiss M, Lübbert C, Stehr SN, Remane Y, Pietsch C, Hönemann M, von Braun A. Regenhardt E, et al. Vaccines (Basel). 2023 May 7;11(5):958. doi: 10.3390/vaccines11050958. Vaccines (Basel). 2023. PMID: 37243062 Free PMC article.

57

Cost-Effectiveness Analysis of COVID-19 Inactivated Vaccines in Reducing the Economic Burden of Ischaemic Stroke after SARS-CoV-2 Infection.

Du M, Qin C, Liu M, Liu J. Du M, et al. Vaccines (Basel). 2023 May 7;11(5):957. doi: 10.3390/vaccines11050957. Vaccines (Basel). 2023. PMID: 37243061 Free PMC article.

58

Multisystem Inflammatory Syndrome in Children (MIS-C), Possibly Due to COVID-19 mRNA Vaccination.

Keka-Sylaj A, Ramosaj A, Baloku A, Zogaj L, Gjaka P. Keka-Sylaj A, et al. Vaccines (Basel). 2023 May 6;11(5):956. doi: 10.3390/vaccines11050956. Vaccines (Basel). 2023. PMID: 37243060 Free PMC article.

59

Role of B Cells in Mycobacterium Tuberculosis Infection.

Stewart P, Patel S, Comer A, Muneer S, Nawaz U, Quann V, Bansal M, Venketaraman V. Stewart P, et al. Vaccines (Basel). 2023 May 6;11(5):955. doi: 10.3390/vaccines11050955. Vaccines (Basel). 2023. PMID: 37243059 Free PMC article. Review.

60

Challenges in Assessing COVID-19 Vaccines Safety Signals-The Case of ChAdOx1 nCoV-19 Vaccine and Corneal Graft Rejection.

Bizimungu C, Sabbe M, Wuillaume F, Hamdani J, Koch P, Dogné JM. Bizimungu C, et al. Vaccines (Basel). 2023 May 6;11(5):954. doi: 10.3390/vaccines11050954. Vaccines (Basel). 2023. PMID: 37243058 Free PMC article.

61

Key Lessons from COVID-19: A Narrative Review Describing Qatar's Multifactorial Approach in Executing a Vaccination Campaign.

Albayat S, Almaslamani M, Alromaihi H, Khogali H, Mundodan J, Joury J, Haridy H. Albayat S, et al. Vaccines (Basel). 2023 May 6;11(5):953. doi: 10.3390/vaccines11050953. Vaccines (Basel). 2023. PMID: 37243057 Free PMC article. Review.

62

Surveying a Sample of the Spanish Ophthalmologic Community about Vaccination against Herpes Zoster.

Sánchez-Mellado A, Alcaraz-Clemente L, Rodríguez-Calvo-de-Mora M, Sánchez-González JM, Ortiz-Perez S, Rocha-de-Lossada C. Sánchez-Mellado A, et al. Vaccines (Basel). 2023 May 5;11(5):952. doi: 10.3390/vaccines11050952. Vaccines (Basel). 2023. PMID: 37243056 Free PMC article.

63

Comparison of Adverse Effects of Two SARS-CoV-2 Vaccines Administered in Workers of the University of Padova.

Mason P, Rizzuto R, Iannelli L, Baccaglini F, Rizzolo V, Baraldo A, Melloni B, Maffione F, Pezzoli C, Chiozza ML, Rupolo G, Biasioli M, Liviero F, Scapellato ML, Trevisan A, Merigliano S, Scuttari A, Moretto A, Scarpa B. Mason P, et al. Vaccines (Basel). 2023 May 5;11(5):951. doi: 10.3390/vaccines11050951. Vaccines (Basel). 2023. PMID: 37243055 Free PMC article.

64

Uneventful Coadministration of Seasonal Influenza and COVID-19 BNT162b2 Vaccines Two Weeks Post-Influenza Vaccination in an Egg-Allergic Subject: A Case Report.

Sayed AA. Sayed AA. Vaccines (Basel). 2023 May 5;11(5):950. doi: 10.3390/vaccines11050950. Vaccines (Basel). 2023. PMID: 37243054 Free PMC article.

65

Factors Affecting Influenza Vaccination Uptake and Attitudes among Lebanese University Students: The Impact of Vaccination Promotional Programs and COVID-19 Pandemic.

Mourad N, Mourad L, Hammoudi Halat D, Farah Z, Hendaus M, El Sayed Trad I, El Akel M, Safwan J, Rahal M, Younes S. Mourad N, et al. Vaccines (Basel). 2023 May 5;11(5):949. doi: 10.3390/vaccines11050949. Vaccines (Basel). 2023. PMID: 37243053 Free PMC article.

66

COVID-19 Vaccine Coverage in India: A District-Level Analysis.

Agarwal SK, Naha M. Agarwal SK, et al. Vaccines (Basel). 2023 May 5;11(5):948. doi: 10.3390/vaccines11050948. Vaccines (Basel). 2023. PMID: 37243052 Free PMC article.

67

Factors Associated with Vaccine Refusal (Polio and Routine Immunization) in High-Risk Areas of Pakistan: A Matched Case-Control Study.

Soofi SB, Vadsaria K, Mannan S, Habib MA, Tabassum F, Hussain I, Muhammad S, Feroz K, Ahmed I, Islam M, Bhutta ZA. Soofi SB, et al. Vaccines (Basel). 2023 May 5;11(5):947. doi: 10.3390/vaccines11050947. Vaccines (Basel). 2023. PMID: 37243051 Free PMC article.

68

Lessons Learned from All for Them: Best Practices for a Cross-Collaboration Approach to HPV Vaccination in Public Schools.

Cuccaro PM, Choi J, Gabay EK, Wilkerson JM, Santa Maria D, Misra SM, Aguilar McBride M, Vernon SW. Cuccaro PM, et al. Vaccines (Basel). 2023 May 5;11(5):946. doi: 10.3390/vaccines11050946. Vaccines (Basel). 2023. PMID: 37243050 Free PMC article.

69

Immune Efficacy of the EV71 Vaccine in Fujian Province, China: A Real-World Analysis of HFMD.

Li J, Xie F, Lin G, Zhang D. Li J, et al. Vaccines (Basel). 2023 May 4;11(5):944. doi: 10.3390/vaccines11050944. Vaccines (Basel). 2023. PMID: 37243049 Free PMC article.

70

Vaccine-Preventable Hospitalisations from Seasonal Respiratory Diseases: What Is Their True Value?

Neri M, Brassel S, Schirrmacher H, Mendes D, Vyse A, Steuten L, Hamson E. Neri M, et al. Vaccines (Basel). 2023 May 4;11(5):945. doi: 10.3390/vaccines11050945. Vaccines (Basel). 2023. PMID: 37243048 Free PMC article.

71

BBIBP-CorV Vaccination against the SARS-CoV-2 Virus Affects the Gut Microbiome.

Shen Y, Dong Y, Jiao J, Wang P, Chen M, Li J. Shen Y, et al. Vaccines (Basel). 2023 May 4;11(5):942. doi: 10.3390/vaccines11050942. Vaccines (Basel). 2023. PMID: 37243047 Free PMC article.

72

The Effect of Pneumococcal, Influenza, and COVID-19 Vaccinations on COVID-19 Hospitalization and Progression in People over 65 Years Old Living in Nursing Homes.

Yilmaz FK, Cakir M, Ikiisik H, Maral I. Yilmaz FK, et al. Vaccines (Basel). 2023 May 4;11(5):943. doi: 10.3390/vaccines11050943. Vaccines (Basel). 2023. PMID: 37243046 Free PMC article.

73

A VLP-Based Vaccine Displaying HBHA and MTP Antigens of Mycobacterium tuberculosis Induces Protective Immune Responses in M. tuberculosis H37Ra Infected Mice.

Wang J, Xie T, Ullah I, Mi Y, Li X, Gong Y, He P, Liu Y, Li F, Li J, Lu Z, Zhu B. Wang J, et al. Vaccines (Basel). 2023 May 4;11(5):941. doi: 10.3390/vaccines11050941. Vaccines (Basel). 2023. PMID: 37243045 Free PMC article.

74

Assessment of Influenza Vaccine Uptake According to the Presence of a Chronic Disease.

Gosadi IM, Zogel B, Alfaifi S, Abusageah F, Hakami KM, Zogel T, Altubayqi T, Darsi A, Almuhaysin G, Ghalibi A, Alhazmi M, Mahla K. Gosadi IM, et al. Vaccines (Basel). 2023 May 4;11(5):938. doi: 10.3390/vaccines11050938. Vaccines (Basel). 2023. PMID: 37243044 Free PMC article.

75

Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK: Does the Adolescent MenACWY Programme Provide Sufficient Protection?

Schley K, Kowalik JC, Sullivan SM, Vyse A, Czudek C, Tichy E, Findlow J. Schley K, et al. Vaccines (Basel). 2023 May 4;11(5):940. doi: 10.3390/vaccines11050940. Vaccines (Basel). 2023. PMID: 37243043 Free PMC article.

76

Use of an ETEC Proteome Microarray to Evaluate Cross-Reactivity of ETVAX^® Vaccine-Induced IgG Antibodies in Zambian Children.

Mubanga C, Simuyandi M, Mwape K, Chibesa K, Chisenga C, Chilyabanyama ON, Randall A, Liang X, Glashoff RH, Chilengi R. Mubanga C, et al. Vaccines (Basel). 2023 May 4;11(5):939. doi: 10.3390/vaccines11050939. Vaccines (Basel). 2023. PMID: 37243042 Free PMC article.

77

Validation of an HPLC-CAD Method for Determination of Lipid Content in LNP-Encapsulated COVID-19 mRNA Vaccines.

Yu X, Yu C, Wu X, Cui Y, Liu X, Jin Y, Li Y, Wang L. Yu X, et al. Vaccines (Basel). 2023 May 4;11(5):937. doi: 10.3390/vaccines11050937. Vaccines (Basel). 2023. PMID: 37243041 Free PMC article.

78

Communication Interventions and Assessment of Drivers for Hendra Virus Vaccination Uptake.

Kropich-Grant JN, Wiley KE, Manyweathers J, Thompson KR, Brookes VJ. Kropich-Grant JN, et al. Vaccines (Basel). 2023 May 4;11(5):936. doi: 10.3390/vaccines11050936. Vaccines (Basel). 2023. PMID: 37243040 Free PMC article. Review.

79

Impact of Health Workers' Choice of COVID-19 Vaccine Booster on Immunization Levels in Istanbul, Turkey.

Ören MM, Canbaz S, Meşe S, Ağaçfidan A, Demir ÖS, Karaca E, Doğruyol AR, Otçu GH, Tükek T, Özgülnar N. Ören MM, et al. Vaccines (Basel). 2023 May 3;11(5):935. doi: 10.3390/vaccines11050935. Vaccines (Basel). 2023. PMID: 37243039 Free PMC article.

80

Graves' Disease after mRNA COVID-19 Vaccination, with the Presence of Autoimmune Antibodies Even One Year Later.

Nakamura F, Awaya T, Ohira M, Enomoto Y, Moroi M, Nakamura M. Nakamura F, et al. Vaccines (Basel). 2023 May 3;11(5):934. doi: 10.3390/vaccines11050934. Vaccines (Basel). 2023. PMID: 37243038 Free PMC article.

81

Cost-Effectiveness of the Use of Adjuvanted Quadrivalent Seasonal Influenza Vaccine in Older Adults in Ireland.

Nguyen VH, Ashraf M, Mould-Quevedo JF. Nguyen VH, et al. Vaccines (Basel). 2023 May 3;11(5):933. doi: 10.3390/vaccines11050933. Vaccines (Basel). 2023. PMID: 37243037 Free PMC article.

82

Influenza Vaccination Implementation in Sri Lanka: A Cost-Effectiveness Analysis.

Neighbors CE, Myers ER, Weerasinghe NP, Wijayaratne GB, Bodinayake CK, Nagahawatte A, Tillekeratne LG, Woods CW. Neighbors CE, et al. Vaccines (Basel). 2023 May 3;11(5):932. doi: 10.3390/vaccines11050932. Vaccines (Basel). 2023. PMID: 37243036 Free PMC article.

83

Enterovirus 71-Associated Infection in South Vietnam: Vaccination Is a Real Solution.

Romanenkova NI, Nguyen TTT, Golitsyna LN, Ponomareva NV, Rozaeva NR, Kanaeva OI, Leonov AV, Novikova NA, Bichurina MA. Romanenkova NI, et al. Vaccines (Basel). 2023 May 3;11(5):931. doi: 10.3390/vaccines11050931. Vaccines (Basel). 2023. PMID: 37243035 Free PMC article.

84

You Shall Not Pass: MX2 Proteins Are Versatile Viral Inhibitors.

Betancor G. Betancor G. Vaccines (Basel). 2023 May 3;11(5):930. doi: 10.3390/vaccines11050930. Vaccines (Basel). 2023. PMID: 37243034 Free PMC article. Review.

85

Awareness and Acceptance for COVID-19 Booster Dose Vaccination among Residents of Saudi Arabia: Findings of a Cross-Sectional Study.

Ahmad MS, Almuteri TD, Alharbi AOM, Tawakul A, Alturiqy MAM, Alzahrani M, Almutairi SB, Almutairi GM, Alotaibi AS, Almutairi NS, Alhabdan LK, Alghuyaythat WKZ. Ahmad MS, et al. Vaccines (Basel). 2023 May 3;11(5):929. doi: 10.3390/vaccines11050929. Vaccines (Basel). 2023. PMID: 37243033 Free PMC article.

86

Willingness to Pay for HPV Vaccine among Women Living with HIV in Nigeria.

Akinsolu FT, Abodunrin O, Adewole IE, Olagunju M, Gambari AO, Raji DO, Idigbe IE, Njuguna DW, Salako A, Ezechi OC. Akinsolu FT, et al. Vaccines (Basel). 2023 May 3;11(5):928. doi: 10.3390/vaccines11050928. Vaccines (Basel). 2023. PMID: 37243032 Free PMC article.

87

Combined Live Oral Priming and Intramuscular Boosting Regimen with Rotarix^® and a Nanoparticle-Based Trivalent Rotavirus Vaccine Evaluated in Gnotobiotic Pig Models of G4P[6] and G1P[8] Human Rotavirus Infection.

Hensley C, Nyblade C, Zhou P, Parreño V, Ramesh A, Frazier A, Frazier M, Garrison S, Fantasia-Davis A, Cai R, Huang PW, Xia M, Tan M, Yuan L. Hensley C, et al. Vaccines (Basel). 2023 May 2;11(5):927. doi: 10.3390/vaccines11050927. Vaccines (Basel). 2023. PMID: 37243031 Free PMC article.

88

Why Parents Say No to Having Their Children Vaccinated against Measles: A Systematic Review of the Social Determinants of Parental Perceptions on MMR Vaccine Hesitancy.

Novilla MLB, Goates MC, Redelfs AH, Quenzer M, Novilla LKB, Leffler T, Holt CA, Doria RB, Dang MT, Hewitt M, Lind E, Prickett E, Aldridge K. Novilla MLB, et al. Vaccines (Basel). 2023 May 2;11(5):926. doi: 10.3390/vaccines11050926. Vaccines (Basel). 2023. PMID: 37243030 Free PMC article. Review.

89

Effects of Electrochemotherapy on Immunologically Important Modifications in Tumor Cells.

Kesar U, Markelc B, Jesenko T, Ursic Valentinuzzi K, Cemazar M, Strojan P, Sersa G. Kesar U, et al. Vaccines (Basel). 2023 Apr 30;11(5):925. doi: 10.3390/vaccines11050925. Vaccines (Basel). 2023. PMID: 37243029 Free PMC article.

90

Return on Investment (ROI) of Three Vaccination Programmes in Italy: HPV at 12 Years, Herpes Zoster in Adults, and Influenza in the Elderly.

Barbieri M, Boccalini S. Barbieri M, et al. Vaccines (Basel). 2023 Apr 30;11(5):924. doi: 10.3390/vaccines11050924. Vaccines (Basel). 2023. PMID: 37243028 Free PMC article.

91

Development of Effective PEDV Vaccine Candidates Based on Viral Culture and Protease Activity.

Kim DM, Moon SH, Kim SC, Cho HS, Tark D. Kim DM, et al. Vaccines (Basel). 2023 Apr 30;11(5):923. doi: 10.3390/vaccines11050923. Vaccines (Basel). 2023. PMID: 37243027 Free PMC article.

92

Role of Psychosomatic Symptoms in COVID-19 Vaccine Hesitancy.

Desai S, Kainth T, Yadav G, Kochhar H, Srinivas S, Kamil S, Du W. Desai S, et al. Vaccines (Basel). 2023 Apr 30;11(5):922. doi: 10.3390/vaccines11050922. Vaccines (Basel). 2023. PMID: 37243026 Free PMC article.

93

Associated Factors and Immune Response to the Hepatitis B Vaccine with a Standard Schedule: A Prospective Study of People with HIV in China.

Nie L, Hua W, Liu X, Pang X, Guo C, Zhang W, Tian Y, Qiu Q. Nie L, et al. Vaccines (Basel). 2023 Apr 29;11(5):921. doi: 10.3390/vaccines11050921. Vaccines (Basel). 2023. PMID: 37243025 Free PMC article.

94

Varying Cellular Immune Response against SARS-CoV-2 after the Booster Vaccination: A Cohort Study from Fukushima Vaccination Community Survey, Japan.

Tani Y, Takita M, Kobashi Y, Wakui M, Zhao T, Yamamoto C, Saito H, Kawashima M, Sugiura S, Nishikawa Y, Omata F, Shimazu Y, Kawamura T, Sugiyama A, Nakayama A, Kaneko Y, Kodama T, Kami M, Tsubokura M. Tani Y, et al. Vaccines (Basel). 2023 Apr 29;11(5):920. doi: 10.3390/vaccines11050920. Vaccines (Basel). 2023. PMID: 37243024 Free PMC article.

95

Engineered Phage-Based Cancer Vaccines: Current Advances and Future Directions.

Ragothaman M, Yoo SY. Ragothaman M, et al. Vaccines (Basel). 2023 Apr 29;11(5):919. doi: 10.3390/vaccines11050919. Vaccines (Basel). 2023. PMID: 37243023 Free PMC article. Review.

96

Circulation of Pestiviruses in Small Ruminants from Greece: First Molecular Identification of Border Disease Virus.

Bouzalas IG, Gelasakis AI, Chassalevris T, Apostolidi ED, Pappas F, Ekateriniadou L, Boukouvala E, Zdragas A. Bouzalas IG, et al. Vaccines (Basel). 2023 Apr 28;11(5):918. doi: 10.3390/vaccines11050918. Vaccines (Basel). 2023. PMID: 37243022 Free PMC article.

97

The Economic Value of Rotavirus Vaccination When Optimally Implemented in a High-Income Country.

Standaert B. Standaert B. Vaccines (Basel). 2023 Apr 28;11(5):917. doi: 10.3390/vaccines11050917. Vaccines (Basel). 2023. PMID: 37243021 Free PMC article.

98

Seroprevalence of SARS-CoV-2 and Vaccination Coverage among Residents of a Lower-Middle-Class Population in the Federal District, Brazil.

Nogueira de Brito R, Passarella Teixeira AI, Carvalho Gontijo C, Da Silva Faria R, Massa Ramalho W, Sierra Romero GA, Castro M, Pessoa V, Araújo Torres L, Pereira Leite L, Ferreira Noronha E, Haddad R, Navegantes de Araújo W. Nogueira de Brito R, et al. Vaccines (Basel). 2023 Apr 28;11(5):916. doi: 10.3390/vaccines11050916. Vaccines (Basel). 2023. PMID: 37243020 Free PMC article.

99

Polyethylene Glycol and Polysorbate 80 Skin Tests in the Context of an Allergic Risk Assessment for Hypersensitivity Reactions to Anti-SARS-CoV-2 mRNA Vaccines.

Nappi E, Racca F, Piona A, Messina MR, Ferri S, Lamacchia D, Cataldo G, Costanzo G, Del Moro L, Puggioni F, Canonica GW, Heffler E, Paoletti G. Nappi E, et al. Vaccines (Basel). 2023 Apr 28;11(5):915. doi: 10.3390/vaccines11050915. Vaccines (Basel). 2023. PMID: 37243019 Free PMC article.

100

Liposome and QS-21 Combined Adjuvant Induces theHumoral and Cellular Responses of Acellular Pertussis Vaccine in a Mice Model.

Yang B, Zhu D, Zhou Y, Gong B, Hu Y, Zhang J, Huang S, Nian X, Li X, Li X, Duan K, Yang X. Yang B, et al. Vaccines (Basel). 2023 Apr 28;11(5):914. doi: 10.3390/vaccines11050914. Vaccines (Basel). 2023. PMID: 37243018 Free PMC article.

101

Inequality in Immunization: Holding on to Equity as We 'Catch Up'.

Nambiar D, Hosseinpoor AR, Bergen N, Danovaro-Holliday MC, Wallace A, Johnson HL. Nambiar D, et al. Vaccines (Basel). 2023 Apr 28;11(5):913. doi: 10.3390/vaccines11050913. Vaccines (Basel). 2023. PMID: 37243017 Free PMC article.

102

Correlates of Parental Consent to Human Papillomavirus Vaccine Uptake by Their Adolescent Daughters in ZAMBIA: Application of the Health Belief Model.

Lubeya MK, Chibwesha CJ, Mwanahamuntu M, Mukosha M, Maposa I, Kawonga M. Lubeya MK, et al. Vaccines (Basel). 2023 Apr 28;11(5):912. doi: 10.3390/vaccines11050912. Vaccines (Basel). 2023. PMID: 37243016 Free PMC article.

103

Role of Healthcare Professionals and Sociodemographic Characteristics in COVID-19 Vaccination Acceptance among Uro-Oncology Patients: A Cross-Sectional Observational Study.

Nikic P, Stankovic B, Santric V, Vukovic I, Babic U, Radovanovic M, Bojanic N, Acimovic M, Kovacevic L, Prijovic N. Nikic P, et al. Vaccines (Basel). 2023 Apr 28;11(5):911. doi: 10.3390/vaccines11050911. Vaccines (Basel). 2023. PMID: 37243015 Free PMC article.

104

Construction of a Triple-Gene Deletion Mutant of Orf Virus and Evaluation of Its Safety, Immunogenicity and Protective Efficacy.

Shen Z, Liu B, Zhu Z, Du J, Zhou Z, Pan C, Chen Y, Yin C, Luo Y, Li H, Chen X. Shen Z, et al. Vaccines (Basel). 2023 Apr 28;11(5):909. doi: 10.3390/vaccines11050909. Vaccines (Basel). 2023. PMID: 37243014 Free PMC article.

105

Desensitization Protocols for Anti-SARS-CoV-2 Vaccines in Patients with High Risk of Allergic Reactions.

Messina MR, Crisciotti C, Pellegrini L, Nappi E, Racca F, Costanzo G, Del Moro L, Ferri S, Puggioni F, Canonica GW, Heffler E, Paoletti G. Messina MR, et al. Vaccines (Basel). 2023 Apr 27;11(5):910. doi: 10.3390/vaccines11050910. Vaccines (Basel). 2023. PMID: 37243013 Free PMC article.

106

Pneumococcal Vaccination in Adults: A Narrative Review of Considerations for Individualized Decision-Making.

See KC. See KC. Vaccines (Basel). 2023 Apr 27;11(5):908. doi: 10.3390/vaccines11050908. Vaccines (Basel). 2023. PMID: 37243012 Free PMC article. Review.

107

The Psychology of COVID-19 Booster Hesitancy, Acceptance and Resistance in Australia.

Kleitman S, Fullerton DJ, Law MKH, Blanchard MD, Campbell R, Tait MA, Schulz J, Lee J, Stankov L, King MT. Kleitman S, et al. Vaccines (Basel). 2023 Apr 27;11(5):907. doi: 10.3390/vaccines11050907. Vaccines (Basel). 2023. PMID: 37243011 Free PMC article.

108

Vaccine Confidence and Uptake of the Omicron Bivalent Booster in Tennessee: Implications for Vulnerable Populations.

Alcendor DJ, Matthews-Juarez P, Smoot D, Edwards A, Hildreth JEK, Juarez PD. Alcendor DJ, et al. Vaccines (Basel). 2023 Apr 27;11(5):906. doi: 10.3390/vaccines11050906. Vaccines (Basel). 2023. PMID: 37243010 Free PMC article. Review.

109

Viral Pneumonia during the COVID-19 Pandemic, 2019-2021 Evoking Needs for SARS-CoV-2 and Additional Vaccinations.

Lin SC, Wang HC, Lin WC, Kuo YT, Hsu YH, Tsai YT, Lu SC, Wang YH, Chen SY. Lin SC, et al. Vaccines (Basel). 2023 Apr 27;11(5):905. doi: 10.3390/vaccines11050905. Vaccines (Basel). 2023. PMID: 37243009 Free PMC article.

110

COVID-19 Vaccines Status, Acceptance and Hesitancy among Maintenance Hemodialysis Patients: A Cross-Sectional Study and the Implications for Pakistan and Beyond.

Amjad Z, Maryam I, Munir M, Salman M, Baraka MA, Mustafa ZU, Khan YH, Mallhi TH, Hasan SS, Meyer JC, Godman B. Amjad Z, et al. Vaccines (Basel). 2023 Apr 27;11(5):904. doi: 10.3390/vaccines11050904. Vaccines (Basel). 2023. PMID: 37243008 Free PMC article.

111

The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic Hospital.

Paoletti G, Pepys J, Bragato MC, Paoletti S, Piona A, Messina MR, Racca F, Ferri S, Nappi E, Costanzo G, Del Moro L, Puggioni F, Canonica GW, Azzolini E, Heffler E. Paoletti G, et al. Vaccines (Basel). 2023 Apr 27;11(5):903. doi: 10.3390/vaccines11050903. Vaccines (Basel). 2023. PMID: 37243007 Free PMC article.

112

Adjuvants for COVID-19 Vaccines.

Castrodeza-Sanz J, Sanz-Muñoz I, Eiros JM. Castrodeza-Sanz J, et al. Vaccines (Basel). 2023 Apr 26;11(5):902. doi: 10.3390/vaccines11050902. Vaccines (Basel). 2023. PMID: 37243006 Free PMC article. Review.

113

Simultaneous Multiple-Stages Mpox Genital Lesions on the Same Site in a Traveler to Greece: A Case Report.

Tagka A, Geronikolou S, Evaggelopoulos A, Grigoropoulou S, Kavatha D, Botsi C, Papadopoulou A, Tryfinopoulou K, Katsoulidou A, Pappa S, Papa A, Paparizos V, Nicolaidou E, Tsiodras S, Stratigos AJ. Tagka A, et al. Vaccines (Basel). 2023 Apr 26;11(5):901. doi: 10.3390/vaccines11050901. Vaccines (Basel). 2023. PMID: 37243005 Free PMC article.

114

"Zero Dose" Children in the Democratic Republic of the Congo: How Many and Who Are They?

Ishoso DK, Danovaro-Holliday MC, Cikomola AM, Lungayo CL, Mukendi JC, Mwamba D, Ngandu C, Mafuta E, Lusamba Dikassa PS, Lulebo A, Manirakiza D, Mboussou FF, Yapi MD, Ngabo GF, Riziki RB, Mwanga C, Otomba J, Nimpa MM. Ishoso DK, et al. Vaccines (Basel). 2023 Apr 26;11(5):900. doi: 10.3390/vaccines11050900. Vaccines (Basel). 2023. PMID: 37243004 Free PMC article.

115

Calcinosis Cutis and Calciphylaxis in Autoimmune Connective Tissue Diseases.

Mormile I, Mosella F, Turco P, Napolitano F, de Paulis A, Rossi FW. Mormile I, et al. Vaccines (Basel). 2023 Apr 25;11(5):898. doi: 10.3390/vaccines11050898. Vaccines (Basel). 2023. PMID: 37243003 Free PMC article. Review.

116

Vaccination and Factors Related to the Clinical Outcome of COVID-19 in Healthcare Workers-A Romanian Front-Line Hospital's Experience.

Chivu CD, Crăciun MD, Pițigoi D, Aramă V, Luminos ML, Jugulete G, Apostolescu CG, Streinu Cercel A. Chivu CD, et al. Vaccines (Basel). 2023 Apr 25;11(5):899. doi: 10.3390/vaccines11050899. Vaccines (Basel). 2023. PMID: 37243002 Free PMC article.

117

Previous Vaccination History and Psychological Factors as Significant Predictors of Willingness to Receive Mpox Vaccination and a Favorable Attitude towards Compulsory Vaccination.

Mahameed H, Al-Mahzoum K, AlRaie LA, Aburumman R, Al-Naimat H, Alhiary S, Barakat M, Al-Tammemi AB, Salim NA, Sallam M. Mahameed H, et al. Vaccines (Basel). 2023 Apr 25;11(5):897. doi: 10.3390/vaccines11050897. Vaccines (Basel). 2023. PMID: 37243001 Free PMC article.

118

Living with HIV and Getting Vaccinated: A Narrative Review.

De Vito A, Colpani A, Trunfio M, Fiore V, Moi G, Fois M, Leoni N, Ruiu S, Babudieri S, Calcagno A, Madeddu G. De Vito A, et al. Vaccines (Basel). 2023 Apr 25;11(5):896. doi: 10.3390/vaccines11050896. Vaccines (Basel). 2023. PMID: 37243000 Free PMC article. Review.

119

A Qualitative Investigation on COVID-19 Vaccine Hesitancy in Neurodivergent Communities.

Khorasani LN, Bastani A, Shen T, Kaur G, Shah ND, Juarez L, Heyman M, Grassian J, Cho AC, Hotez E. Khorasani LN, et al. Vaccines (Basel). 2023 Apr 25;11(5):895. doi: 10.3390/vaccines11050895. Vaccines (Basel). 2023. PMID: 37242999 Free PMC article.

120

Humoral Response after a Fourth Dose with mRNA-1273 in Healthcare Workers with and without a History of SARS-CoV-2 Infection and Previously Vaccinated with Two Doses of BBIBP-CorV Plus BNT162b2 Vaccine.

Gómez de la Torre JC, Hueda-Zavaleta M, Cáceres-DelAguila JA, Muro-Rojo C, Cruz-Escurra N, Benítes-Zapata VA. Gómez de la Torre JC, et al. Vaccines (Basel). 2023 Apr 25;11(5):894. doi: 10.3390/vaccines11050894. Vaccines (Basel). 2023. PMID: 37242998 Free PMC article.

121

Effectiveness and Safety of SARS-CoV-2 Vaccination in HIV-Infected Patients-Real-World Study.

Bociąga-Jasik M, Lara M, Raczyńska A, Wizner B, Polański S, Mlicka-Kowalczyk E, Garlicki A, Sanak M. Bociąga-Jasik M, et al. Vaccines (Basel). 2023 Apr 24;11(5):893. doi: 10.3390/vaccines11050893. Vaccines (Basel). 2023. PMID: 37242997 Free PMC article.

122

Effectiveness and Safety of Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) among Healthcare Workers: A Seven-Month Follow-Up Study at Fifteen Central Hospitals.

Ashmawy R, Kamal E, Amin W, Sharaf S, Kabeel S, Albiheyri R, El-Maradny YA, Hassanin E, Elsaka N, Fahmy O, Awd A, Aboeldahab H, Nayle M, Afifi M, Ibrahim M, Rafaat R, Aly S, Redwan EM. Ashmawy R, et al. Vaccines (Basel). 2023 Apr 24;11(5):892. doi: 10.3390/vaccines11050892. Vaccines (Basel). 2023. PMID: 37242996 Free PMC article.

123

Assessing the Efficacy of the 3R (Reframe, Reprioritize, and Reform) Communication Model to Increase HPV Vaccinations Acceptance in Ghana: Community-Based Intervention.

Asare M, Agyei-Baffour P, Koranteng A, Commeh ME, Fosu ES, Elizondo A, Sturdivant RX. Asare M, et al. Vaccines (Basel). 2023 Apr 24;11(5):890. doi: 10.3390/vaccines11050890. Vaccines (Basel). 2023. PMID: 37242995 Free PMC article.

124

Evaluation of an Immunization Protocol Using Bovine Alphaherpesvirus 1 gE-Deleted Marker Vaccines against Bubaline Alphaherpesvirus 1 in Water Buffaloes.

Martucciello A, Balestrieri A, Righi C, Cappelli G, Scoccia E, Grassi C, Brandi S, Rossi E, Galiero G, Gioia D, Fusco G, Feliziani F, De Carlo E, Petrini S. Martucciello A, et al. Vaccines (Basel). 2023 Apr 24;11(5):891. doi: 10.3390/vaccines11050891. Vaccines (Basel). 2023. PMID: 37242994 Free PMC article.

125

Coping Strategies for Pertussis Resurgence.

Nian X, Liu H, Cai M, Duan K, Yang X. Nian X, et al. Vaccines (Basel). 2023 Apr 24;11(5):889. doi: 10.3390/vaccines11050889. Vaccines (Basel). 2023. PMID: 37242993 Free PMC article. Review.

126

Assessment of Immune Responses to Rabies Vaccination in Free-Ranging Dogs in Bengaluru, India.

Prakash Rao VC, Ramakrishnaiah S, Isloor S, Doddamane R, Lakshman D, Maralavadi MSSR, Bhat A, Chandrashekar B, Natesan K, Kondabattula G, Hegde NR. Prakash Rao VC, et al. Vaccines (Basel). 2023 Apr 24;11(5):888. doi: 10.3390/vaccines11050888. Vaccines (Basel). 2023. PMID: 37242992 Free PMC article.

127

Mucosal Vaccination Strategies against Clostridioides difficile Infection.

Heuler J, Chandra H, Sun X. Heuler J, et al. Vaccines (Basel). 2023 Apr 23;11(5):887. doi: 10.3390/vaccines11050887. Vaccines (Basel). 2023. PMID: 37242991 Free PMC article. Review.

128

COVID-19 Vaccine Acceptance, Attitude and Perception among Slum and Underserved Communities: A Systematic Review and Meta-Analysis.

Kawuki J, Chen S, Fang Y, Liang X, Chan PS, Wang Z. Kawuki J, et al. Vaccines (Basel). 2023 Apr 23;11(5):886. doi: 10.3390/vaccines11050886. Vaccines (Basel). 2023. PMID: 37242990 Free PMC article. Review.

129

Comparative Evaluation of Intradermal vis-à-vis Intramuscular Pre-Exposure Prophylactic Vaccination against Rabies in Cattle.

Gopalaiah S, Appaiah KM, Isloor S, Lakshman D, Thimmaiah RP, Rao S, Gouri M, Kumar N, Govindaiah K, Bhat A, Tiwari S. Gopalaiah S, et al. Vaccines (Basel). 2023 Apr 23;11(5):885. doi: 10.3390/vaccines11050885. Vaccines (Basel). 2023. PMID: 37242989 Free PMC article.

130

Long COVID and Hybrid Immunity among Children and Adolescents Post-Delta Variant Infection in Thailand.

Jarupan M, Jantarabenjakul W, Jaruampornpan P, Subchartanan J, Phasomsap C, Sritammasiri T, Cartledge S, Suchartlikitwong P, Anugulruengkitt S, Kawichai S, Puthanakit T. Jarupan M, et al. Vaccines (Basel). 2023 Apr 23;11(5):884. doi: 10.3390/vaccines11050884. Vaccines (Basel). 2023. PMID: 37242988 Free PMC article.

131

Before and After: Attitude and Adverse Effects Induced by the First and Second Doses of mRNA BNT162b2 Vaccine among Healthcare Professionals in the First Weeks after Their Introduction in Poland.

Pasternak G, Pieniawska-Śmiech K, Walkowiak M, Sado J, Pytel A, Jasińska P, Kierbiedź-Guzik N, Bolaczek P, Fleischer-Stępniewska K, Babicki M, Pentoś K, Lewandowicz-Uszyńska A. Pasternak G, et al. Vaccines (Basel). 2023 Apr 22;11(5):883. doi: 10.3390/vaccines11050883. Vaccines (Basel). 2023. PMID: 37242987 Free PMC article.

132

Synergistic Effect between SARS-CoV-2 Wave and COVID-19 Vaccination on the Occurrence of Mild Symptoms in Healthcare Workers.

Imeshtari V, Vezza F, Barletta VI, Bongiovanni A, Colaprico C, Shaholli D, Ricci E, Carluccio G, Moretti L, Manai MV, Chiappetta M, Paolini R, Marte M, Previte CM, Barone LC, Faticoni A, Cammalleri V, Pocino RN, Picchioni F, Kibi S, Deriu G, Serruto P, Dorelli B, Mazzalai E, Giffi M, Marotta D, Manzi M, Marasca V, Cocchiara RA, Ciccone F, Pasculli P, Massetti P, Antonelli G, Mastroianni CM, La Torre G. Imeshtari V, et al. Vaccines (Basel). 2023 Apr 22;11(5):882. doi: 10.3390/vaccines11050882. Vaccines (Basel). 2023. PMID: 37242986 Free PMC article.

133

Protective Efficacy of Multiple Epitope-Based Vaccine against Hyalomma anatolicum, Vector of Theileria annulata and Crimean-Congo Hemorrhagic Fever Virus.

Nandi A, Manisha, Solanki V, Tiwari V, Sajjanar B, Sankar M, Saini M, Shrivastava S, Bhure SK, Ghosh S. Nandi A, et al. Vaccines (Basel). 2023 Apr 21;11(4):881. doi: 10.3390/vaccines11040881. Vaccines (Basel). 2023. PMID: 37112793 Free PMC article.

134

Differences in the Expression Levels of SARS-CoV-2 Spike Protein in Cells Treated with mRNA-Based COVID-19 Vaccines: A Study on Vaccines from the Real World.

Cari L, Naghavi Alhosseini M, Mencacci A, Migliorati G, Nocentini G. Cari L, et al. Vaccines (Basel). 2023 Apr 21;11(4):879. doi: 10.3390/vaccines11040879. Vaccines (Basel). 2023. PMID: 37112792 Free PMC article.

135

Healthcare Workers' Attitudes towards Mandatory COVID-19 Vaccination: A Systematic Review and Meta-Analysis.

Politis M, Sotiriou S, Doxani C, Stefanidis I, Zintzaras E, Rachiotis G. Politis M, et al. Vaccines (Basel). 2023 Apr 21;11(4):880. doi: 10.3390/vaccines11040880. Vaccines (Basel). 2023. PMID: 37112791 Free PMC article. Review.

136

Knowledge of Community Pharmacists in Saudi Arabia Regarding Human Monkeypox, Its Management, Prevention, and Vaccination: Findings and Implications.

Alrasheedy AA, Aldawsari AH, Alqasir MI, Alsawyan OA, Alalwan OA, Alwaker SA, Almutairi MS, Godman B. Alrasheedy AA, et al. Vaccines (Basel). 2023 Apr 21;11(4):878. doi: 10.3390/vaccines11040878. Vaccines (Basel). 2023. PMID: 37112790 Free PMC article.

137

Innate Immune Response Assessment in Cyprinus carpio L. upon Experimental Administration with Artemia salina Bio-Encapsulated Aeromonas hydrophila Bacterin.

Radhakrishnan A, Prabakaran DS, Ramesh T, Sakthivel R, Ramasamy K, Han HS, Jeyachandran S. Radhakrishnan A, et al. Vaccines (Basel). 2023 Apr 21;11(4):877. doi: 10.3390/vaccines11040877. Vaccines (Basel). 2023. PMID: 37112789 Free PMC article.

138

Bolstering the Measurement of Racial Inequity of COVID-19 Vaccine Uptake.

Russ S, Bramley J, Liu Y, Boyce I. Russ S, et al. Vaccines (Basel). 2023 Apr 21;11(4):876. doi: 10.3390/vaccines11040876. Vaccines (Basel). 2023. PMID: 37112788 Free PMC article.

139

Immune Imprinting and Implications for COVID-19.

Zhou Z, Barrett J, He X. Zhou Z, et al. Vaccines (Basel). 2023 Apr 20;11(4):875. doi: 10.3390/vaccines11040875. Vaccines (Basel). 2023. PMID: 37112787 Free PMC article. Review.

140

Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell^®.

Rabdano SO, Ruzanova EA, Pletyukhina IV, Saveliev NS, Kryshen KL, Katelnikova AE, Beltyukov PP, Fakhretdinova LN, Safi AS, Rudakov GO, Arakelov SA, Andreev IV, Kofiadi IA, Khaitov MR, Valenta R, Kryuchko DS, Berzin IA, Belozerova NS, Evtushenko AE, Truhin VP, Skvortsova VI. Rabdano SO, et al. Vaccines (Basel). 2023 Apr 20;11(4):874. doi: 10.3390/vaccines11040874. Vaccines (Basel). 2023. PMID: 37112786 Free PMC article.

141

Factors Influencing the Intention and Uptake of COVID-19 Vaccines on the African Continent: A Scoping Review.

Naidoo D, Meyer-Weitz A, Govender K. Naidoo D, et al. Vaccines (Basel). 2023 Apr 20;11(4):873. doi: 10.3390/vaccines11040873. Vaccines (Basel). 2023. PMID: 37112785 Free PMC article. Review.

142

Using Electronic Reminders to Improve Human Papillomavirus (HPV) Vaccinations among Primary Care Patients.

Hanley K, Chung TH, Nguyen LK, Amadi T, Stansberry S, Yetman RJ, Foxhall LE, Bello R, Diallo T, Le YL. Hanley K, et al. Vaccines (Basel). 2023 Apr 20;11(4):872. doi: 10.3390/vaccines11040872. Vaccines (Basel). 2023. PMID: 37112784 Free PMC article.

143

Views and Perceptions of People Aged 55+ on the Vaccination Programme for Older Adults in the UK: A Qualitative Study.

Silvonen T, Kesten J, Cabral C, Coast J, Ben-Shlomo Y, Christensen H. Silvonen T, et al. Vaccines (Basel). 2023 Apr 20;11(4):870. doi: 10.3390/vaccines11040870. Vaccines (Basel). 2023. PMID: 37112783 Free PMC article.

144

SARS-CoV-2 Neutralizing Antibodies to B.1 and to BA.5 Variant after Booster Dose of BNT162b2 Vaccine in HIV Patients COVID-Naïve and on Successful Antiretroviral Therapy.

Vicenti I, Basso M, Pirola N, Bragato B, Rossi MC, Giobbia M, Pascoli S, Vinci A, Caputo S, Varasi I, Biba C, Fiaschi L, Zazzi M, Parisi SG. Vicenti I, et al. Vaccines (Basel). 2023 Apr 20;11(4):871. doi: 10.3390/vaccines11040871. Vaccines (Basel). 2023. PMID: 37112782 Free PMC article.

145

Health Systems Determinants of Delivery and Uptake of Maternal Vaccines in Low- and Middle-Income Countries: A Qualitative Systematic Review.

Davies B, Olivier J, Amponsah-Dacosta E. Davies B, et al. Vaccines (Basel). 2023 Apr 19;11(4):869. doi: 10.3390/vaccines11040869. Vaccines (Basel). 2023. PMID: 37112781 Free PMC article. Review.

146

Examining the Impact of Key Factors on COVID-19 Vaccination Coverage in India: A PLS-SEM Approach.

Dhawan V, Aggarwal MK, Dhalaria P, Kharb P, Sharma D, Dinesh KK, Dhir S, Sushil, Taneja G, Ghosh RS. Dhawan V, et al. Vaccines (Basel). 2023 Apr 19;11(4):868. doi: 10.3390/vaccines11040868. Vaccines (Basel). 2023. PMID: 37112780 Free PMC article.

147

Genomic Analysis of Infectious Bursal Disease Virus in Nigeria: Identification of Unique Mutations of Yet Unknown Biological Functions in Both Segments A and B.

Nwagbo I, Milani A, Salviato A, Zamperin G, Sulaiman L, Maurice N, Meseko C, Fusaro A, Shittu I. Nwagbo I, et al. Vaccines (Basel). 2023 Apr 19;11(4):867. doi: 10.3390/vaccines11040867. Vaccines (Basel). 2023. PMID: 37112779 Free PMC article.

148

Dissolving Microneedles Loaded with Nanoparticle Formulation of Respiratory Syncytial Virus Fusion Protein Virus-like Particles (F-VLPs) Elicits Cellular and Humoral Immune Responses.

Menon I, Patil S, Bagwe P, Vijayanand S, Kale A, Braz Gomes K, Kang SM, D'Souza M. Menon I, et al. Vaccines (Basel). 2023 Apr 18;11(4):866. doi: 10.3390/vaccines11040866. Vaccines (Basel). 2023. PMID: 37112778 Free PMC article.

149

Identification and Evaluation of Novel Antigen Candidates against Salmonella Pullorum Infection Using Reverse Vaccinology.

Jiang Z, Kang X, Song Y, Zhou X, Yue M. Jiang Z, et al. Vaccines (Basel). 2023 Apr 18;11(4):865. doi: 10.3390/vaccines11040865. Vaccines (Basel). 2023. PMID: 37112777 Free PMC article.

150

Combination of Recombinant Proteins S1/N and RBD/N as Potential Vaccine Candidates.

Mendoza-Ramírez NJ, García-Cordero J, Martínez-Frías SP, Roa-Velázquez D, Luria-Pérez R, Bustos-Arriaga J, Hernández-Lopez J, Cabello-Gutiérrez C, Zúñiga-Ramos JA, Morales-Ríos E, Pérez-Tapia SM, Espinosa-Cantellano M, Cedillo-Barrón L. Mendoza-Ramírez NJ, et al. Vaccines (Basel). 2023 Apr 18;11(4):864. doi: 10.3390/vaccines11040864. Vaccines (Basel). 2023. PMID: 37112776 Free PMC article.

151

Effectiveness, Immunogenicity and Harms of Additional SARS-CoV-2 Vaccine Doses in Kidney Transplant Recipients: A Systematic Review.

Hausinger RI, Bachmann Q, Crone-Rawe T, Hannane N, Monsef I, Haller B, Heemann U, Skoetz N, Kreuzberger N, Schmaderer C. Hausinger RI, et al. Vaccines (Basel). 2023 Apr 18;11(4):863. doi: 10.3390/vaccines11040863. Vaccines (Basel). 2023. PMID: 37112775 Free PMC article. Review.

152

Safety and Immunogenicity of Enterovirus 71 Vaccine (Vero Cell) Administered Simultaneously with Trivalent Split-Virion Influenza Vaccine in Infants Aged 6-7 Months: A Phase 4, Randomized, Controlled Trial.

Xiao Y, Guo X, Zhang M, Chen Y, Zhang Y, Yu X, Luo L, Chen H, Xu W, Liu H, Wu L, Hou R, Ma Y, Long L, Ruan J, Chen W, Yang X. Xiao Y, et al. Vaccines (Basel). 2023 Apr 18;11(4):862. doi: 10.3390/vaccines11040862. Vaccines (Basel). 2023. PMID: 37112774 Free PMC article.

153

Clinical Characteristics and Outcomes among Vaccinated and Unvaccinated Patients with Cardiovascular Disease Who Were Hospitalized for COVID-19 in Brazil: Retrospective Cohort.

Sardinha DM, Ferreira ALDS, Guimarães RJPSE, Lima KVB, Lima LNGC. Sardinha DM, et al. Vaccines (Basel). 2023 Apr 18;11(4):861. doi: 10.3390/vaccines11040861. Vaccines (Basel). 2023. PMID: 37112773 Free PMC article.

154

Longitudinal Changes in IgG-Type SARS-CoV-2 Antibody Titers after COVID-19 Vaccination and a Prominent Increase in Antibody Titers When Infected after Vaccination.

Kusunoki H, Ohkusa M, Iida R, Saito A, Kawahara M, Ekawa K, Kato N, Yamasaki K, Motone M, Shimizu H. Kusunoki H, et al. Vaccines (Basel). 2023 Apr 17;11(4):860. doi: 10.3390/vaccines11040860. Vaccines (Basel). 2023. PMID: 37112772 Free PMC article.

155

The Impact of a Revised National Childhood Immunization Schedule on Vaccination Defaulters.

Tan NC, Pang J, Koh E. Tan NC, et al. Vaccines (Basel). 2023 Apr 17;11(4):859. doi: 10.3390/vaccines11040859. Vaccines (Basel). 2023. PMID: 37112771 Free PMC article.

156

COVID-19 Vaccine Acceptance and Hesitancy in Health Care Workers in Somalia: Findings from a Fragile Country with No Previous Experience of Mass Adult Immunization.

Ibrahim AM, Hamayoun M, Farid M, Al-Umra U, Shube M, Sumaili K, Shamalla L, Malik SMMR. Ibrahim AM, et al. Vaccines (Basel). 2023 Apr 17;11(4):858. doi: 10.3390/vaccines11040858. Vaccines (Basel). 2023. PMID: 37112770 Free PMC article.

157

Assessing the Impact of Vaccination on the Dynamics of COVID-19 in Africa: A Mathematical Modeling Study.

Montcho Y, Nalwanga R, Azokpota P, Doumatè JT, Lokonon BE, Salako VK, Wolkewitz M, Glèlè Kakaï R. Montcho Y, et al. Vaccines (Basel). 2023 Apr 17;11(4):857. doi: 10.3390/vaccines11040857. Vaccines (Basel). 2023. PMID: 37112769 Free PMC article.

158

PP19128R, a Multiepitope Vaccine Designed to Prevent Latent Tuberculosis Infection, Induced Immune Responses In Silico and In Vitro Assays.

Jiang F, Peng C, Cheng P, Wang J, Lian J, Gong W. Jiang F, et al. Vaccines (Basel). 2023 Apr 17;11(4):856. doi: 10.3390/vaccines11040856. Vaccines (Basel). 2023. PMID: 37112768 Free PMC article.

159

BCG-Vaccinated Children with Contact to Tuberculosis Patients Show Delayed Conversion of Mycobacterium tuberculosis-Specific IFN-γ Release.

Owusu DO, Adankwah E, Aniagyei W, Acheampong I, Minadzi D, Yeboah A, Arthur JF, Lamptey M, Vivekanandan MM, Abass MK, Kumbel F, Osei-Yeboah F, Gawusu A, Batsa Debrah L, Debrah A, Mayatepek E, Seyfarth J, Phillips RO, Jacobsen M. Owusu DO, et al. Vaccines (Basel). 2023 Apr 17;11(4):855. doi: 10.3390/vaccines11040855. Vaccines (Basel). 2023. PMID: 37112767 Free PMC article.

160

T-ALL Cells as Tool Cells for CAR T Therapy.

Ren A, Zhao Y, Zhu H. Ren A, et al. Vaccines (Basel). 2023 Apr 17;11(4):854. doi: 10.3390/vaccines11040854. Vaccines (Basel). 2023. PMID: 37112766 Free PMC article.

161

Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2.

Van Egeren D, Stoddard M, White LF, Hochberg NS, Rogers MS, Zetter B, Joseph-McCarthy D, Chakravarty A. Van Egeren D, et al. Vaccines (Basel). 2023 Apr 16;11(4):853. doi: 10.3390/vaccines11040853. Vaccines (Basel). 2023. PMID: 37112765 Free PMC article.

162

Multicentric Observational Study on Safety and Tolerability of COVID-19 Vaccines in Patients with Angioedema with C1 Inhibitor Deficiency: Data from Italian Network on Hereditary and Acquired Angioedema (ITACA).

Parente R, Sartorio S, Brussino L, De Pasquale T, Zoli A, Agolini S, Di Agosta E, Quattrocchi P, Borrelli P, Bignardi D, Petraroli A, Senter R, Popescu Janu V, Cogliati C, Guarino MD, Rossi O, Firinu D, Pucci S, Spadaro G, Triggiani M, Cancian M, Zanichelli A. Parente R, et al. Vaccines (Basel). 2023 Apr 16;11(4):852. doi: 10.3390/vaccines11040852. Vaccines (Basel). 2023. PMID: 37112764 Free PMC article.

163

What Determines the District-Level Disparities in Immunization Coverage in India: Findings from Five Rounds of the National Family Health Survey.

Saikia N, Kumar K, Bora JK, Mondal S, Phad S, Agarwal S. Saikia N, et al. Vaccines (Basel). 2023 Apr 16;11(4):851. doi: 10.3390/vaccines11040851. Vaccines (Basel). 2023. PMID: 37112763 Free PMC article.

164

Perspectives Associated with Human Papillomavirus Vaccination in Adults: A Qualitative Study.

Cernasev A, Hohmeier KC, Oyedeji O, Hagemann T, Kintziger KW, Wisdom T, Gatwood J. Cernasev A, et al. Vaccines (Basel). 2023 Apr 15;11(4):850. doi: 10.3390/vaccines11040850. Vaccines (Basel). 2023. PMID: 37112762 Free PMC article.

165

SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines.

Sunagar R, Singh A, Kumar S. Sunagar R, et al. Vaccines (Basel). 2023 Apr 15;11(4):849. doi: 10.3390/vaccines11040849. Vaccines (Basel). 2023. PMID: 37112761 Free PMC article. Review.

166

Demographic and Psychosocial Correlates of COVID-19 Vaccination Status among a Statewide Sample in Texas.

Luningham JM, Akpan IN, Taskin T, Alkhatib S, Vishwanatha JK, Thompson EL. Luningham JM, et al. Vaccines (Basel). 2023 Apr 15;11(4):848. doi: 10.3390/vaccines11040848. Vaccines (Basel). 2023. PMID: 37112760 Free PMC article.

167

Involvement of the MGF 110-11L Gene in the African Swine Fever Replication and Virulence.

Tamás V, Righi C, Mészáros I, D'Errico F, Olasz F, Casciari C, Zádori Z, Magyar T, Petrini S, Feliziani F. Tamás V, et al. Vaccines (Basel). 2023 Apr 14;11(4):846. doi: 10.3390/vaccines11040846. Vaccines (Basel). 2023. PMID: 37112759 Free PMC article.

168

Attitudes and Behaviors towards Vaccination in Portuguese Nursing Students.

Marques-Vieira CMA, Domingues TD, Tholl AD, Nitschke RG, Pérez-Rivas FJ, Ajejas-Bazán MJ, Roquette-Viana MC. Marques-Vieira CMA, et al. Vaccines (Basel). 2023 Apr 14;11(4):847. doi: 10.3390/vaccines11040847. Vaccines (Basel). 2023. PMID: 37112758 Free PMC article.

169

Long-Term Follow-Up after Adoptive Transfer of BK-Virus-Specific T Cells in Hematopoietic Stem Cell Transplant Recipients.

Koldehoff M, Eiz-Vesper B, Maecker-Kolhoff B, Steckel NK, Dittmer U, Horn PA, Lindemann M. Koldehoff M, et al. Vaccines (Basel). 2023 Apr 14;11(4):845. doi: 10.3390/vaccines11040845. Vaccines (Basel). 2023. PMID: 37112757 Free PMC article.

170

Implementation and Delivery of Oral Cholera Vaccination Campaigns in Humanitarian Crisis Settings among Rohingya Myanmar nationals in Cox's Bazar, Bangladesh.

Khan AI, Islam MT, Khan ZH, Tanvir NA, Amin MA, Khan II, Bhuiyan ATMRH, Hasan ASMM, Islam MS, Bari TIA, Rahman A, Islam MN, Qadri F. Khan AI, et al. Vaccines (Basel). 2023 Apr 14;11(4):843. doi: 10.3390/vaccines11040843. Vaccines (Basel). 2023. PMID: 37112756 Free PMC article. Review.

171

Factors of Compliance of Dental Patients in Primary Health Care Services during the Pandemic.

Zachari S, Papagiannis D, Kotsiou O, Malli F, Fradelos EC, Gourgoulianis KI. Zachari S, et al. Vaccines (Basel). 2023 Apr 14;11(4):844. doi: 10.3390/vaccines11040844. Vaccines (Basel). 2023. PMID: 37112755 Free PMC article.

172

Efficacy of Six Different SARS-CoV-2 Vaccines during a Six-Month Follow-Up and Five COVID-19 Waves in Brazil and Mexico.

Romero-Ibarguengoitia ME, Rivera-Salinas D, Sarti R, Levi R, Mollura M, Garza-Silva A, Rivera-Cavazos A, Hernández-Ruíz YG, Barco-Flores IA, González-Cantú A, Sanz-Sánchez MÁ, Guimarães Júnior MH, Pozzi C, Barbieri R, Morales-Rodriguez DP, Texeira MM, Rescigno M. Romero-Ibarguengoitia ME, et al. Vaccines (Basel). 2023 Apr 14;11(4):842. doi: 10.3390/vaccines11040842. Vaccines (Basel). 2023. PMID: 37112754 Free PMC article.

173

Development of an Integrated Continuous Manufacturing Process for the rVSV-Vectored SARS-CoV-2 Candidate Vaccine.

Yang Z, Paes BCMF, Fulber JPC, Tran MY, Farnós O, Kamen AA. Yang Z, et al. Vaccines (Basel). 2023 Apr 14;11(4):841. doi: 10.3390/vaccines11040841. Vaccines (Basel). 2023. PMID: 37112753 Free PMC article.

174

Cellular and Humoral Immune Responses to Vaccination for COVID-19 Are Negatively Impacted by Senescent T Cells: A Case Report.

Rosseto-Welter EA, Rodrigues SS, de Figueiredo AB, França CN, Oliveira DBL, Bachi ALL, do Amaral JB, Siqueira RA, Bento LC, da Silva AP, Bacal NS, Dos Santos Ferreira CE, Mangueira CLP, Pinho JRR. Rosseto-Welter EA, et al. Vaccines (Basel). 2023 Apr 14;11(4):840. doi: 10.3390/vaccines11040840. Vaccines (Basel). 2023. PMID: 37112752 Free PMC article.

175

COVID-19 Vaccine Refusal and Delay among Adults in Italy: Evidence from the OBVIOUS Project, a National Survey in Italy.

Gori D, Capodici A, La Fauci G, Montalti M, Salussolia A, Soldà G, Di Valerio Z, Scognamiglio F, Fantini MP, Leask J, Larson HJ, Profeti S, Toth F, Lenzi J, On Behalf Of The Other Researchers Of The Obvious Board. Gori D, et al. Vaccines (Basel). 2023 Apr 13;11(4):839. doi: 10.3390/vaccines11040839. Vaccines (Basel). 2023. PMID: 37112751 Free PMC article.

176

Low Vaccine Coverage and Factors Associated with Incomplete Childhood Immunization in Racial/Ethnic Minorities and Rural Groups, Central Brazil.

de Oliveira Roque E Lima J, Pagotto V, Rocha BS, Scalize PS, Guimarães RA, de Lima MD, da Silva LN, da Silva Oliveira MD, Moura WÉA, Teles SA, Rosso CFW, Caetano KAA. de Oliveira Roque E Lima J, et al. Vaccines (Basel). 2023 Apr 13;11(4):838. doi: 10.3390/vaccines11040838. Vaccines (Basel). 2023. PMID: 37112750 Free PMC article.

177

Engaging Faith-Based Organizations for Promoting the Uptake of COVID-19 Vaccine in India: A Case Study of a Multi-Faith Society.

Soni GK, Bhatnagar A, Gupta A, Kumari A, Arora S, Seth S, Rastogi A, Kanagat N, Fields R. Soni GK, et al. Vaccines (Basel). 2023 Apr 13;11(4):837. doi: 10.3390/vaccines11040837. Vaccines (Basel). 2023. PMID: 37112749 Free PMC article.

178

Exploring the Pattern of Immunization Dropout among Children in India: A District-Level Comparative Analysis.

Dhalaria P, Kapur S, Singh AK, Priyadarshini P, Dutta M, Arora H, Taneja G. Dhalaria P, et al. Vaccines (Basel). 2023 Apr 13;11(4):836. doi: 10.3390/vaccines11040836. Vaccines (Basel). 2023. PMID: 37112748 Free PMC article.

179

T Cell Based Immunotherapy for Cancer: Approaches and Strategies.

Want MY, Bashir Z, Najar RA. Want MY, et al. Vaccines (Basel). 2023 Apr 13;11(4):835. doi: 10.3390/vaccines11040835. Vaccines (Basel). 2023. PMID: 37112747 Free PMC article. Review.

180

COVID-19 Anti-Vaccine Sentiments in Malaysia: Narratives of Comments from Facebook Post.

Wong LP, Alias H, Wong YL, Megat Hashim MMAA, Lin Y, Hu Z. Wong LP, et al. Vaccines (Basel). 2023 Apr 13;11(4):834. doi: 10.3390/vaccines11040834. Vaccines (Basel). 2023. PMID: 37112746 Free PMC article.

181

A Recombinant RBD-Based Phage Vaccine Report: A Solution to the Prevention of New Diseases?

Salehi Z, Rasaee MJ. Salehi Z, et al. Vaccines (Basel). 2023 Apr 13;11(4):833. doi: 10.3390/vaccines11040833. Vaccines (Basel). 2023. PMID: 37112745 Free PMC article.

182

A SARS-CoV-2 Vaccine Designed for Manufacturability Results in Unexpected Potency and Non-Waning Humoral Response.

Campbell E, Dobkin J, Osorio LJ, Kolloli A, Ramasamy S, Kumar R, Sant'Angelo DB, Subbian S, Denzin LK, Anderson S. Campbell E, et al. Vaccines (Basel). 2023 Apr 12;11(4):832. doi: 10.3390/vaccines11040832. Vaccines (Basel). 2023. PMID: 37112744 Free PMC article.

183

Development of MVA-d34 Tetravalent Dengue Vaccine: Design and Immunogenicity.

Mintaev RR, Glazkova DV, Orlova OV, Ignatyev GM, Oksanich AS, Shipulin GA, Bogoslovskaya EV. Mintaev RR, et al. Vaccines (Basel). 2023 Apr 12;11(4):831. doi: 10.3390/vaccines11040831. Vaccines (Basel). 2023. PMID: 37112743 Free PMC article.

184

Early Oral Administration of Ginseng Stem-Leaf Saponins Enhances the Peyer's Patch-Dependent Maternal IgA Antibody Response to a PEDV Inactivated Vaccine in Mice, with Gut Microbiota Involvement.

Su F, Li J, Xue Y, Yu B, Ye S, Xu L, Fu Y, Yuan X. Su F, et al. Vaccines (Basel). 2023 Apr 12;11(4):830. doi: 10.3390/vaccines11040830. Vaccines (Basel). 2023. PMID: 37112742 Free PMC article.

185

Identification of Anti-gp41 Monoclonal Antibodies That Effectively Target Cytotoxic Immunoconjugates to Cells Infected with Human Immunodeficiency Virus, Type 1.

Klug G, Cole FM, Hicar MD, Watt C, Peters T, Pincus SH. Klug G, et al. Vaccines (Basel). 2023 Apr 12;11(4):829. doi: 10.3390/vaccines11040829. Vaccines (Basel). 2023. PMID: 37112741 Free PMC article.

186

The Willingness toward Vaccination: A Focus on Non-Mandatory Vaccinations.

Capodici A, Sanmarchi F, Bonaccorso N, Costantino C, Maietti E. Capodici A, et al. Vaccines (Basel). 2023 Apr 11;11(4):828. doi: 10.3390/vaccines11040828. Vaccines (Basel). 2023. PMID: 37112740 Free PMC article.

187

IgG1-Dominant Antibody Response Induced by Recombinant Trimeric SARS-CoV-2 Spike Protein with PIKA Adjuvant.

Wang J, Mai X, He Y, Zhu C, Zhou D. Wang J, et al. Vaccines (Basel). 2023 Apr 11;11(4):827. doi: 10.3390/vaccines11040827. Vaccines (Basel). 2023. PMID: 37112739 Free PMC article.

188

Comparison of Biological, Pharmacological Characteristics, Indications, Contraindications, Efficacy, and Adverse Effects of Inactivated Whole-Virus COVID-19 Vaccines Sinopharm, CoronaVac, and Covaxin: An Observational Study.

Meo SA, ElToukhy RA, Meo AS, Klonoff DC. Meo SA, et al. Vaccines (Basel). 2023 Apr 11;11(4):826. doi: 10.3390/vaccines11040826. Vaccines (Basel). 2023. PMID: 37112738 Free PMC article.

189

Feeding Spray-Dried Porcine Plasma to Pigs Improves the Protection Afforded by the African Swine Fever Virus (ASFV) BA71∆CD2 Vaccine Prototype against Experimental Challenge with the Pandemic ASFV-Study 2.

Pujols J, Blázquez E, Segalés J, Rodríguez F, Chang CY, Argilaguet J, Bosch-Camós L, Rosell R, Pailler-García L, Gavrilov B, Campbell J, Polo J. Pujols J, et al. Vaccines (Basel). 2023 Apr 10;11(4):825. doi: 10.3390/vaccines11040825. Vaccines (Basel). 2023. PMID: 37112737 Free PMC article.

190

Feeding Spray-Dried Porcine Plasma to Pigs Reduces African Swine Fever Virus Load in Infected Pigs and Delays Virus Transmission-Study 1.

Blázquez E, Pujols J, Rodríguez F, Segalés J, Rosell R, Campbell J, Polo J. Blázquez E, et al. Vaccines (Basel). 2023 Apr 10;11(4):824. doi: 10.3390/vaccines11040824. Vaccines (Basel). 2023. PMID: 37112736 Free PMC article.

191

Investing in the Prevention of Communicable Disease Outbreaks: Fiscal Health Modelling-The Tool of Choice for Assessing Public Finance Sustainability.

van der Schans S, Schöttler MH, van der Schans J, Connolly MP, Postma MJ, Boersma C. van der Schans S, et al. Vaccines (Basel). 2023 Apr 10;11(4):823. doi: 10.3390/vaccines11040823. Vaccines (Basel). 2023. PMID: 37112735 Free PMC article.

192

Gender Differences of the Effect of Vaccination on Perceptions of COVID-19 and Mental Health in Japan.

Yamamura E, Kohsaka Y, Tsutsui Y, Ohtake F. Yamamura E, et al. Vaccines (Basel). 2023 Apr 10;11(4):822. doi: 10.3390/vaccines11040822. Vaccines (Basel). 2023. PMID: 37112734 Free PMC article.

193

A Ferritin Nanoparticle-Based Zika Virus Vaccine Candidate Induces Robust Humoral and Cellular Immune Responses and Protects Mice from Lethal Virus Challenge.

Pattnaik A, Sahoo BR, Struble LR, Borgstahl GEO, Zhou Y, Franco R, Barletta RG, Osorio FA, Petro TM, Pattnaik AK. Pattnaik A, et al. Vaccines (Basel). 2023 Apr 10;11(4):821. doi: 10.3390/vaccines11040821. Vaccines (Basel). 2023. PMID: 37112733 Free PMC article.

194

Incomplete HPV Vaccination among Individuals Aged 27-45 Years in the United States: A Mixed-Effect Analysis of Individual and Contextual Factors.

Adekanmbi V, Guo F, Hsu CD, Shan Y, Kuo YF, Berenson AB. Adekanmbi V, et al. Vaccines (Basel). 2023 Apr 10;11(4):820. doi: 10.3390/vaccines11040820. Vaccines (Basel). 2023. PMID: 37112732 Free PMC article.

195

Safety and Immunogenicity Following the Second and Third Doses of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents with Juvenile-Onset Autoimmune Inflammatory Rheumatic Diseases: A Prospective Multicentre Study.

Heshin-Bekenstein M, Ziv A, Toplak N, Lazauskas S, Kadishevich D, Ben-Nun Yaari E, Miller-Barmak A, Butbul Aviel Y, Saiag E, Pel S, Elkayam O, Uziel Y, Furer V. Heshin-Bekenstein M, et al. Vaccines (Basel). 2023 Apr 10;11(4):819. doi: 10.3390/vaccines11040819. Vaccines (Basel). 2023. PMID: 37112731 Free PMC article.

196

Toll-Like Receptors and the Response to Radiotherapy in Solid Tumors: Challenges and Opportunities.

Haroun R, Naasri S, Oweida AJ. Haroun R, et al. Vaccines (Basel). 2023 Apr 7;11(4):818. doi: 10.3390/vaccines11040818. Vaccines (Basel). 2023. PMID: 37112730 Free PMC article. Review.

197

Social Media Sentiment about COVID-19 Vaccination Predicts Vaccine Acceptance among Peruvian Social Media Users the Next Day.

Lokmanoglu AD, Nisbet EC, Osborne MT, Tien J, Malloy S, Cueva Chacón L, Villa Turek E, Abhari R. Lokmanoglu AD, et al. Vaccines (Basel). 2023 Apr 7;11(4):817. doi: 10.3390/vaccines11040817. Vaccines (Basel). 2023. PMID: 37112729 Free PMC article.

198

How Well the Constructs of Health Belief Model Predict Vaccination Intention: A Systematic Review on COVID-19 Primary Series and Booster Vaccines.

Limbu YB, Gautam RK. Limbu YB, et al. Vaccines (Basel). 2023 Apr 7;11(4):816. doi: 10.3390/vaccines11040816. Vaccines (Basel). 2023. PMID: 37112728 Free PMC article. Review.

199

Evaluation of Container Clinics as an Urban Immunization Strategy: Findings from the First Year of Implementation in Ghana, 2017-2018.

Shaum A, Wardle MT, Amponsa-Achiano K, Aborigo R, Opare J, Wallace AS, Bandoh D, Quaye P, Osei-Sarpong F, Abotsi F, Bonsu G, Conklin L. Shaum A, et al. Vaccines (Basel). 2023 Apr 7;11(4):814. doi: 10.3390/vaccines11040814. Vaccines (Basel). 2023. PMID: 37112727 Free PMC article.

200

Immunogenicity and Protection against Foot-and-Mouth Disease Virus in Swine Intradermally Vaccinated with a Bivalent Vaccine of Foot-and-Mouth Disease Virus Type O and A.

Kim DW, Cho G, Kim H, Lee G, Lim TG, Kwak HY, Park JH, Park SH. Kim DW, et al. Vaccines (Basel). 2023 Apr 7;11(4):815. doi: 10.3390/vaccines11040815. Vaccines (Basel). 2023. PMID: 37112726 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

6,004 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

6,004 results

Results by year